| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $172.35M | $23.68M | $0.00 | $0.00 | $139.71M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $445.44M | $363.35M | $229.95M | $151.76M | $113.49M |
| R&D | $258.78M | $241.65M | $163.03M | $118.50M | $88.25M |
| SG&A | $179.68M | $120.88M | $66.92M | $33.26M | $25.24M |
| Operating Income | -$273.08M | -$339.67M | -$229.95M | -$151.76M | $26.22M |
| Interest Expense | – | – | $208.00K | $3.14M | $1.90M |
| Tax Expense | $433.00K | – | – | – | $0.00 |
| Net Income | -$285.42M | -$318.76M | -$209.36M | -$149.34M | $24.93M |
| EPS (basic) | -3.2900 | -3.7200 | -2.9800 | -2.4600 | 0.4800 |
| EPS (diluted) | -3.2900 | -3.7200 | -2.9800 | -2.4600 | 0.4600 |
| Shares (diluted) | $86.63M | $85.62M | $70.37M | $60.76M | $53.62M |